|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2008-7-23
|
|
pubmed:abstractText |
This study was designed to evaluate whether plasma asymmetric dimethylarginine (ADMA) has any role in predicting hemodynamic responses in clinically healthy young subjects. ADMA, as an endogenous nitric oxide (NO) synthase inhibitor, has been demonstrated to associate with hypertension and vascular reactivity in experimental but not undoubtedly in physiological settings.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0895-7061
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
873-8
|
|
pubmed:dateRevised |
2009-2-24
|
|
pubmed:meshHeading |
pubmed-meshheading:18551100-Adult,
pubmed-meshheading:18551100-Arginine,
pubmed-meshheading:18551100-Blood Pressure,
pubmed-meshheading:18551100-Cardiovascular Diseases,
pubmed-meshheading:18551100-Female,
pubmed-meshheading:18551100-Finland,
pubmed-meshheading:18551100-Humans,
pubmed-meshheading:18551100-Kidney,
pubmed-meshheading:18551100-Lipids,
pubmed-meshheading:18551100-Male,
pubmed-meshheading:18551100-Nitric Oxide,
pubmed-meshheading:18551100-Risk Factors,
pubmed-meshheading:18551100-Vascular Resistance,
pubmed-meshheading:18551100-Vasoconstriction,
pubmed-meshheading:18551100-Young Adult
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Asymmetric dimethylarginine (ADMA) has a role in regulating systemic vascular tone in young healthy subjects: the cardiovascular risk in young Finns study.
|
|
pubmed:affiliation |
Emergency Department, University Hospital of Tampere, Tampere, Finland. hannu.paiva@pshp.fi
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
